LFG
TBPH icon

Larson Financial Group’s Theravance Biopharma TBPH Stock Holding History

Larson Financial Group’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.53K Buy
279
+109
+64% +$1.93K ﹤0.01% 2652
2025
Q4 		$3.18K Hold
170
– – ﹤0.01% 2643
2025
Q3 		$2.48K Hold
170
– – ﹤0.01% 2615
2025
Q2 		$1.88K Buy
170
+116
+215% +$1.13K ﹤0.01% 2428
2025
Q1 		$482 Buy
+54
New +$503 ﹤0.01% 2586

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Larson Financial Group's TBPH Position: Q1 2026 in Review

Larson Financial Group increased its Theravance Biopharma (TBPH) stake by 64% in Q1 2026, buying an estimated $1.93K and bringing the position to 279 shares worth $4.53K. The position accounts for ﹤0.01% of the portfolio, ranked #2652.

Larson Financial Group first reported a position in TBPH in Q1 2025 and has held it in 5 quarters since. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Larson Financial Group held 279 shares of Theravance Biopharma worth $4.53K as of Q1 2026.
  • Larson Financial Group bought 109 Theravance Biopharma shares in Q1 2026, an estimated $1.93K.
  • Theravance Biopharma made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2652 holding.
  • Larson Financial Group first reported a position in Theravance Biopharma in Q1 2025 and has held it in 5 quarters since.
  • 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.